Skip to content
a16za16z

OpenAI’s Head of Health AI on Whether You Should Trust ChatGPT

More than 300 million people use ChatGPT for health and wellness questions each week. OpenAI’s Karan Singhal thinks that’s only the beginning: the longer-term goal is AI that can help people navigate their health proactively, while making trustworthy medical intelligence dramatically more accessible. Karan joins a16z Partner Jay Rughani to explain why OpenAI trains healthcare expertise directly into its general-purpose frontier models, how it works with hundreds of medical experts to evaluate safety and disagreement, and why the company sees AI as a complement to doctors rather than a replacement for medical care. They also discuss integrations with Epic, AI copilots for clinicians, and what happens as personal agents begin navigating appointments, health records, and other fragmented parts of the healthcare system. Looking further ahead, Karan makes the case that the cost of medical intelligence could continue to fall dramatically, allowing AI to act as a safety net for patients and clinicians, surface insights from years of health data, and potentially accelerate the discovery and validation of new treatments. Timestamps: 00:00 Intro 01:00 The story of Nathan Labenz's son 07:57 A doctor in your pocket 14:20 Teaching AI who it's talking to 19:44 Medical consensus and its 5–17 year lag 28:03 The mental health problem 30:59 Information vs actual care 38:21 A "move 37" for health 43:39 Driving down the cost of care 50:27 Procedural care and what's next Resources: Follow Karan Singhal on X: https://x.com/thekaransinghal Follow Jay Rughani on X: https://x.com/JayRughani Stay Updated: If you enjoyed this episode, be sure to like, subscribe, and share with your friends! Find a16z on X: https://twitter.com/a16z Find a16z on LinkedIn: https://www.linkedin.com/company/a16z Listen to the a16z Show on Spotify: https://open.spotify.com/show/5bC65RDvs3oxnLyqqvkUYX Listen to the a16z Show on Apple Podcasts: https://podcasts.apple.com/us/podcast/a16z-podcast/id842818711 Follow our host: https://x.com/eriktorenberg Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see http://a16z.com/disclosures.

Jay RughanihostKaran Singhalguest
Oct 20, 202655mWatch on YouTube ↗

CHAPTERS

  1. 0:00 – 4:39

    Why health needs abundant intelligence (and what people ask ChatGPT)

    The conversation opens with the scale and scarcity of healthcare and why OpenAI prioritizes health as a key “upside” area for AI. Karan describes how hundreds of millions of people use ChatGPT for health questions, often to fill gaps between infrequent, short clinician visits.

    • •Healthcare spend is massive, yet access and time with clinicians are scarce
    • •OpenAI frames health as a mission-critical domain: raise the floor and the ceiling
    • •300M+ weekly health/wellness users use ChatGPT to navigate questions and next steps
    • •AI helps most between visits: preparation, follow-ups, interpretation, and logistics
  2. 4:39 – 5:59

    A real patient journey: AI helping detect a child’s leukemia earlier

    Karan recounts the story of Nathan Labenz’s son, where AI helped the family recognize severity, seek testing, and interpret information during a difficult period. The chapter illustrates how AI can reduce uncertainty and provide support when specialist access is delayed.

    • •Symptoms (fatigue/irritability) initially ambiguous; AI helped escalate appropriately
    • •AI supported decision-making while traveling and before specialist interpretation
    • •Use cases: understanding lab reports, making sense of evolving clinical information
    • •Emotional benefit: peace of mind and better navigation through a complex journey
  3. 5:59 – 7:50

    Why a general-purpose model can be medically specialized

    Jay presses on why OpenAI uses a general model for medicine rather than a standalone healthcare model. Karan argues for “specialized training inside a general model,” so health capability improves alongside frontier reasoning progress.

    • •OpenAI adds healthcare data across multiple phases of training
    • •General frontier models improve rapidly; small specialized forks can lag quickly
    • •Approach aims for “best of both worlds”: scale + domain specialization
    • •Physician collaboration contributes specialized data and evaluations
  4. 7:50 – 10:04

    The “doctor in your pocket” vision: personalization, memory, and proactive nudges

    They explore a future experience where AI becomes a proactive personal health assistant—contextual, personalized, and always available—without replacing clinicians. Karan emphasizes privacy boundaries and broad distribution, including free global access.

    • •Vision: cross-specialty guidance, personal history, preferences, and coaching
    • •Not a replacement for doctors—an always-on companion across the care journey
    • •Users can connect health info securely; not used for ads/training (as described)
    • •Focus on global reach: most health users are free-tier and outside the US
  5. 10:04 – 11:54

    AI as a safety net: second opinions, clinician copilots, and proactive flags

    Jay and Karan discuss using AI to routinely provide additional checks in clinical scenarios. Karan cites clinician-copilot experiments (e.g., medication interactions) and anticipates similar patient-side guardrails for chronic conditions.

    • •Goal: a “safety net” that augments rather than interferes
    • •Clinician copilot can flag potential issues (e.g., drug interactions) proactively
    • •Patient-side support: reminders and flags (e.g., rising A1C and medication review)
    • •AI could make multi-opinion review cheap and routine
  6. 11:54 – 14:10

    Agents and the fragmented healthcare system: scheduling, insurance, and connectors

    The discussion shifts to agentic workflows—systems that can carry objectives across tools—to reduce healthcare friction. Karan notes healthcare’s legacy software reality and why connectors (including EHR integrations) matter to overcome fragmentation.

    • •Agents could coordinate scheduling, benefits checks, adherence, and billing disputes
    • •Healthcare has legacy systems; connectivity won’t be instant or universal
    • •Computer-use/VM-like setups may be a pragmatic bridge for automation
    • •Breaking fragmentation is central to making AI useful at the point of care
  7. 14:10 – 16:02

    Trust part 1: tailoring answers by persona (patient vs clinician)

    Jay drills into trust, starting with how the same model should respond differently depending on the user. Karan describes evaluation and training with expert feedback to calibrate jargon, depth, and framing for different personas.

    • •Health adoption “moves at the speed of trust”
    • •Models are evaluated/trained to match persona: lay user, experienced patient, clinician
    • •Benchmarks (e.g., Health Bench) explicitly test communication appropriateness
    • •Trust requires not only performance but transparent measurement and communication
  8. 16:02 – 20:19

    Trust part 2: disagreement, uncertainty, and safety-first behavior

    They address cases where users want reassurance but clinical guidance should be more urgent, plus what to do when doctors disagree with AI. Karan explains OpenAI’s emphasis on aggregated expert consensus, safety prioritization, and uncertainty awareness.

    • •Single-doctor labels aren’t enough; OpenAI uses a broad global clinician network
    • •When objectives conflict (reassurance vs safety), safety is prioritized
    • •Models are trained to recommend seeking care in unsafe scenarios
    • •Disagreement with a doctor: treat it like any second opinion—consult another clinician
    • •Handling uncertainty includes explicit hedging and recognizing limits
  9. 20:19 – 27:15

    Medical consensus has a 5–17 year lag: using AI to compress translation to practice

    Karan explains how knowledge moves from papers to guidelines to real-world practice—and how slow that last step is. AI can bring current literature and guideline reasoning into the moment of care to shorten the gap dramatically.

    • •Pipeline: biomedical literature → clinical guidelines → everyday practice
    • •Studies suggest guideline adoption can take 5–17 years
    • •AI can surface latest evidence at the point of care within minutes
    • •A key goal: reduce “practicing in the past” by integrating up-to-date knowledge
  10. 27:15 – 29:12

    Mental health: safety floors, positive outcomes, and measuring what ‘help’ means

    Jay asks how an AI interprets broad mental health goals like “feel better.” Karan describes safeguards for crisis support and the creation of Mental Health Bench to evaluate not just harm prevention but also positive, helpful experiences.

    • •Commitment to crisis support and consistent safeguards across product surfaces
    • •Mental health is high-disagreement; requires expert consensus-building
    • •Mental Health Bench aims to measure both safety and beneficial support quality
    • •Goal: a shared industry measuring stick to drive improvement
  11. 29:12 – 30:59

    Information vs care delivery: where OpenAI stops and partners begin

    Jay distinguishes medical information from actual care (prescriptions, imaging, exams, liability, empathy). Karan positions OpenAI as an enabler and “quarterback” for navigation—improving the last mile by making it easier for partners who deliver care.

    • •AI won’t provide all elements of care (physical exams, liability, bedside presence)
    • •OpenAI focuses on enabling the ecosystem rather than owning end-to-end care
    • •Role includes navigation, coordination, and reducing fragmentation for patients
    • •Clinicians and care organizations remain central for delivery and accountability
  12. 30:59 – 37:34

    Enterprise and clinician adoption: Epic/UCSF integrations and admin cost reductions

    Karan gives concrete examples of deployment: EHR integration with Epic, early adopter workflows at UCSF, and agent-driven administrative savings at Advent Health. They also discuss shifting patient/clinician attitudes toward seeing ChatGPT in the exam room.

    • •Epic connector: ChatGPT in Epic workflows and Epic access within ChatGPT
    • •UCSF: early use for chart review and reducing workflow fragmentation
    • •Advent Health: reported large reductions in administrative workflow costs
    • •Overton window shifting: both clinicians and patients increasingly see AI as a safety aid
    • •If both sides pre-research, visits can focus on human, physical, and nuanced judgment
  13. 37:34 – 42:51

    A “Move 37” for health: new patterns, antibiotic stewardship, and longitudinal prediction

    They explore whether AI can reveal non-obvious strategies in medicine the way AlphaGo did in Go. Karan points to early examples like reducing inappropriate antibiotics and predicts bigger breakthroughs from integrating long-term, multi-source patient data.

    • •“Move 37” analogy: surprising but correct insights that humans learn from later
    • •Early example: clinician safety nets discouraging unnecessary antibiotics
    • •Future potential: integrating years of EHR + patient history to predict risks
    • •AI could surface patterns no human can compute from volume/complexity of data
  14. 42:51 – 49:40

    Driving down the cost of care: commoditizing health intelligence (and avoiding AI arms races)

    Jay asks how cheaper intelligence affects the $5.3T healthcare economy. Karan argues that model capability is rising while costs drop sharply, but system-wide savings require workflow integration; he also critiques payer-provider AI “arms race” dynamics as avoidable.

    • •Costs fall fast at a fixed capability level; goal is abundant/low-cost health intelligence
    • •Example cited: cheaper API model outperforming a recent best model on clinician benchmarks
    • •Macro savings depend on deployment into admin, documentation, and operations—not just Q&A
    • •Payer-provider bot battles are seen as short-term noise; shared “ground truth” + AI adjudication could reduce conflict
  15. 49:40 – 55:07

    Procedural care and what’s next: prevention first, robotics later, and future therapies

    They close by discussing how AI may affect procedural care—primarily via better targeting and prevention in the near term, with robotics as a longer-term shift. Karan’s longer-horizon prediction is that AI will most impact health through faster drug discovery, prioritization, and clinical trial execution.

    • •Near-term impact on procedural care: better triage/targeting and proactive prevention
    • •Longer-term: robotics and procedural automation face tech and reimbursement hurdles
    • •Two big forward bets: AI-assisted drug target/molecule generation and faster validation
    • •Clinical trials are a bottleneck; AI may help prioritize and run trials more efficiently

Get more out of YouTube videos.

Read along on your phone, search it beside the video, or ask your favorite AI app what was said.

iOSAndroidClaudeChromeChatGPTComing soon